Ossifying Fibromyxoid Tumor: An Update.

Arch Pathol Lab Med

From the Department of Surgical Pathology, Tata Memorial Hospital, Parel, Mumbai, India.

Published: April 2016

Ossifying fibromyxoid tumor (OFMT) is a rare soft tissue neoplasm of uncertain differentiation, initially described by Enzinger and colleagues. Until now, nearly 300 such cases have been reported worldwide. The histogenesis of these tumors remains controversial. These tumors show characteristic imaging findings and exhibit a spectrum of histopathologic features, including classical and atypical subtypes. Local recurrences and, occasionally, distant metastases have also been reported. A complete tumor resection forms the preferred treatment modality for these tumors, along with follow-up, as these tumors have an uncertain malignant potential. Lately, certain "molecular signatures" underlying OFMTs have been described that can further aid in reaching an accurate diagnosis for these tumors and unraveling their pathogenesis. This article is a review of the clinical, radiologic, histopathologic, and molecular features of OFMTs.

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0590-RSDOI Listing

Publication Analysis

Top Keywords

ossifying fibromyxoid
8
fibromyxoid tumor
8
tumors
5
tumor update
4
update ossifying
4
tumor ofmt
4
ofmt rare
4
rare soft
4
soft tissue
4
tissue neoplasm
4

Similar Publications

Ossifying fibromyxoid tumours: A case series.

Eur J Cancer

January 2025

Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address:

Background: Ossifying fibromyxoid tumour is a rare mesenchymal soft tissue sarcoma with uncertain differentiation and variable metastatic potential.

Patients And Methods: This study offers a retrospective analysis of 23 patients diagnosed with OFMT between 1993 and 2024.

Results: The tumours most commonly arose in the extremities and trunk, with all patients undergoing surgical resection of the primary tumour.

View Article and Find Full Text PDF

Aims: Ossifying fibromyxoid tumour is a rare mesenchymal neoplasm predominantly affecting adults characterised by a multinodular growth pattern and the presence of a fibrous pseudocapsule with areas of ossification. Prompted by the recognition of a non-ossifying ossifying fibromyxoid tumour with lipomatous differentiation which caused diagnostic difficulty, we sought to further explore cases of ossifying fibromyxoid tumour with non-osseous heterologous elements.

Methods And Results: A search of our institutional and consultation archives revealed three additional cases that demonstrated lipomatous components and two cases with cartilaginous differentiation.

View Article and Find Full Text PDF

TFE3 rearrangements characterize histogenetically, topographically, and biologically diverse neoplasms. Besides being a universal defining feature in alveolar soft part sarcoma (ASPS) and clear cell stromal tumor of the lung, TFE3 fusions have been reported in subsets of renal cell carcinoma, perivascular epithelioid cell tumor (PEComa), epithelioid hemangioendothelioma and ossifying fibromyxoid tumors. TFE3 -related neoplasms are rare in the head and neck and may pose diagnostic challenges.

View Article and Find Full Text PDF

Ossifying fibromyxoid tumor (OFMT) is a rare soft tissue neoplasm of uncertain origin, exhibiting a wide clinical and morphological spectrum. It ranges from benign forms, which typically behave indolently, to malignant lesions with significant recurrence and metastatic potential. The majority of OFMTs harbor gene rearrangements, with being the most common fusion partner.

View Article and Find Full Text PDF

TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.

Cancers (Basel)

October 2024

Department of Diagnostics and Public Health, Section of Pathology, University of Verona, 37134 Verona, Italy.

Article Synopsis
  • Identical translocations involving the TFE3 gene have been linked to various tumors, including specific renal and soft tissue cancers like alveolar soft part sarcoma and clear cell stromal tumor of the lung.
  • This review focuses on the clinicopathologic and molecular characteristics of TFE3-rearranged renal tumors, highlighting the complexity in their classification due to differing tumor types and features.
  • While the reason for the diverse morphologies associated with similar gene fusions remains unclear, the pathology community still supports maintaining distinct classifications for TFE3-rearranged renal cell carcinoma and TFE3-rearranged PEComa.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!